Simon Schenk
Simon Schenk is an expert in Endocrinology at University of California, San Diego (United States). Simon Schenk has authored 148 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 630 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Genetics - Rheumatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1990 - 2026
Number : 148
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The effect of sex and endurance exercise training on the incretin signaling pathway in 17 rat tissues. PMID 42636194 — exercise, glucagon-like peptide 1, genetics, adrenal glands, incretins, sex, therapeutics, tissues | Physiol Genomics | 2026 | 0 |
| Temporal multi-omic analysis uncovers sex-biased molecular programs underlying skeletal muscle adaptation to endurance training. PMID 42585023 — exercise, muscles, endurance training, biological science disciplines, multiple chronic conditions, sex characteristics, sex, muscle, skeletal, sex differences | Cell Rep | 2026 | 0 |
| Systems modelling of mitochondrial dynamics in different exercise regimes. PMID 42385159 — exercise, cytosol, physiology, muscles, mitochondria, mitochondrial dynamics, systems biology, muscle, skeletal, high-intensity interval training | J Physiol | 2026 | 0 |
| Endurance exercise elicits temporal and sexual dimorphic multi-omics remodeling of liver metabolism revealed by MoTrPAC. PMID 42258354 — exercise, biological science disciplines, multiple chronic conditions, mitochondria, liver, cholesterol, sex | Cell Rep | 2026 | 0 |
| Preclinical evaluation of INS1201 AAV9-micro-dystrophin via CSF administration as a potential therapy for Duchenne muscular dystrophy. PMID 42137291 — genes, muscular dystrophies, muscles, muscular dystrophy, duchenne, pathology, dystrophin, toxicology, therapeutics, preclinical evaluation | Mol Ther Adv | 2026 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map